Research reveals significant role of Axl receptor in progression, therapeutic resista

[News]

BerGenBio AS, an oncology biopharmaceutical company, announces that a paper entitled "Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine cross-talk of leukemia cells with bone marrow stroma" by Ben-Batalla et al., has been published in Blood, the most cited peer-reviewed research journal in the field of hematology.

More... (http://www.news-medical.net/news/20131001/Research-reveals-significant-role-of-Axl-receptor-in-progression-therapeutic-resistance-of-AML.aspx)